Correction to: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer (Molecular Cancer, (2014), 13, 1, (71), 10.1186/1476-4598-13-71)

Claire Corcoran; Sweta Rani; Susan Breslin; Martina Gogarty; Irene M Ghobrial; John Crown; Lorraine O'Driscoll

doi:10.1186/s12943-025-02251-8

Correction to: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer (Molecular Cancer, (2014), 13, 1, (71), 10.1186/1476-4598-13-71)

Claire Corcoran, Sweta Rani, Susan Breslin, Martina Gogarty, Irene M Ghobrial, John Crown, Lorraine O'Driscoll

Department of Science

Research output: Contribution to journal › Comment/debate

Abstract

Following the publication of the original article [1], the authors would like to update Figure 4 as the SKBR3-LR NC mimic migration image presented in the published article was incorrect, but the associated graph showing % fold change was correct. The error was due to a pasting error when compiling the composite figure (two NC mimic invasion images were inadvertently pasted, instead of one NC mimic migration and one NC mimic invasion image). The incorrect and correct figures are provided below.

Original language	English
Article number	37
Pages (from-to)	37
Journal	Molecular cancer
Volume	24
Issue number	1
DOIs	https://doi.org/10.1186/s12943-025-02251-8
Publication status	Published - Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s12943-025-02251-8Licence: CC BY-NC-ND

Fingerprint

Dive into the research topics of 'Correction to: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer (Molecular Cancer, (2014), 13, 1, (71), 10.1186/1476-4598-13-71)'. Together they form a unique fingerprint.

Cite this

Corcoran, C., Rani, S., Breslin, S., Gogarty, M., Ghobrial, I. M., Crown, J., & O'Driscoll, L. (2025). Correction to: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer (Molecular Cancer, (2014), 13, 1, (71), 10.1186/1476-4598-13-71). Molecular cancer, 24(1), 37. Article 37. https://doi.org/10.1186/s12943-025-02251-8

@article{3c21769ce8a24422afd8341b948cb8b7,

title = "Correction to: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer (Molecular Cancer, (2014), 13, 1, (71), 10.1186/1476-4598-13-71)",

abstract = "Following the publication of the original article [1], the authors would like to update Figure 4 as the SKBR3-LR NC mimic migration image presented in the published article was incorrect, but the associated graph showing % fold change was correct. The error was due to a pasting error when compiling the composite figure (two NC mimic invasion images were inadvertently pasted, instead of one NC mimic migration and one NC mimic invasion image). The incorrect and correct figures are provided below.",

author = "Claire Corcoran and Sweta Rani and Susan Breslin and Martina Gogarty and Ghobrial, {Irene M} and John Crown and Lorraine O'Driscoll",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2025",

month = dec,

doi = "10.1186/s12943-025-02251-8",

language = "English",

volume = "24",

pages = "37",

journal = "Molecular cancer",

issn = "1476-4598",

publisher = "BioMed Central Ltd.",

number = "1",

}

Corcoran, C, Rani, S, Breslin, S, Gogarty, M, Ghobrial, IM, Crown, J & O'Driscoll, L 2025, 'Correction to: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer (Molecular Cancer, (2014), 13, 1, (71), 10.1186/1476-4598-13-71)', Molecular cancer, vol. 24, no. 1, 37, pp. 37. https://doi.org/10.1186/s12943-025-02251-8

Correction to: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer (Molecular Cancer, (2014), 13, 1, (71), 10.1186/1476-4598-13-71). / Corcoran, Claire; Rani, Sweta; Breslin, Susan et al.
In: Molecular cancer, Vol. 24, No. 1, 37, 12.2025, p. 37.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer (Molecular Cancer, (2014), 13, 1, (71), 10.1186/1476-4598-13-71)

AU - Corcoran, Claire

AU - Rani, Sweta

AU - Breslin, Susan

AU - Gogarty, Martina

AU - Ghobrial, Irene M

AU - Crown, John

AU - O'Driscoll, Lorraine

PY - 2025/12

Y1 - 2025/12

N2 - Following the publication of the original article [1], the authors would like to update Figure 4 as the SKBR3-LR NC mimic migration image presented in the published article was incorrect, but the associated graph showing % fold change was correct. The error was due to a pasting error when compiling the composite figure (two NC mimic invasion images were inadvertently pasted, instead of one NC mimic migration and one NC mimic invasion image). The incorrect and correct figures are provided below.

AB - Following the publication of the original article [1], the authors would like to update Figure 4 as the SKBR3-LR NC mimic migration image presented in the published article was incorrect, but the associated graph showing % fold change was correct. The error was due to a pasting error when compiling the composite figure (two NC mimic invasion images were inadvertently pasted, instead of one NC mimic migration and one NC mimic invasion image). The incorrect and correct figures are provided below.

UR - http://www.scopus.com/inward/record.url?scp=85217732047&partnerID=8YFLogxK

U2 - 10.1186/s12943-025-02251-8

DO - 10.1186/s12943-025-02251-8

M3 - Comment/debate

C2 - 39891208

SN - 1476-4598

VL - 24

SP - 37

JO - Molecular cancer

JF - Molecular cancer

IS - 1

M1 - 37

ER -

Correction to: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer (Molecular Cancer, (2014), 13, 1, (71), 10.1186/1476-4598-13-71)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this